Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00986284 · SUSPENDED
Trial details
- NCT number
- NCT00986284
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2016-11-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.